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Background
Many molecular systems involved in controlling devel-
opment are also implicated in malignant transformation
and are associated with poorer survival outcomes in
cancer patients. In fact, lung tumours with similar gene
expression profiles to fetal lung cells are associated with
aggressive phenotypes of the disease. As targeting fetal
developmental pathways selectively reactivated in cancer
cells would presumably spare normal adult cells from
toxicity, these pathways are considered ideal therapeutic
targets for cancer treatment. Therefore, a better under-
standing of the interplay between fetal lung develop-
ment and lung cancer on the level of individual
miRNAs will provide new insights for translational
research. In this study we applied sequencing technology
to identify miRNAs with similar expression patterns
between fetal lung and lung tumours.
Patients and methods
Eighty-nine pairs of tumour and adjacent non-malignant
lung and five fetal lung tissue samples were profiled by
miRNA-sequencing. Mann–Whitney U tests were per-
formed with Benjamini-Hochberg multiple testing cor-
rection to identify common expression patterns.
Results
We describe, for the first time, a comprehensive miRNA
expression profile of human fetal lung. We have not
only detected miRNAs that exhibit similar expression
levels between fetal lung and non-malignant lung tissue
which may play roles in lung tissue maintenance, but
also identified multiple miRNAs with similar expression
patterns between fetal lung and lung tumours. Some of
these miRNAs have been previously implicated in lung
cancer, while others have not yet been described to play
a role in this disease. Pathways known to be targeted by
miRNAs commonly expressed between fetal lung and
lung tumours are involved in cell proliferation and
angiogenesis. Further studies will elucidate the specific
roles of these miRNAs in lung tumourigenesis.
Conclusions
We identified several miRNAs with similar expression
profiles between fetal lung and lung tumours which
potentially play critical roles in lung cancer and might
lead to the identification of promising therapeutic targets.
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